Kaleido Stock Stock News Today

KLDO -  USA Stock  

USD 5.78  0.11  1.94%

Kaleido Stock News module provides quick insight into current market opportunities from investing in Kaleido Biosciences. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Kaleido Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please see Kaleido Biosciences Hype Analysis, Kaleido Biosciences Correlation and Kaleido Biosciences Performance.

Search Today's Stock News 

 
Refresh
Kaleido Biosciences stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Kaleido daily returns and investor perception about the current pice of Kaleido Biosciences as well as its diversification or hedging effects on your existing portfolios.
few days ago at www.pharmaceutical-technology.com         
Setback of Seress late-stage candidate challenges microbiome space - register for free webinar - pha...
P
over a week ago at www.equities.com         
Kaleido Biosciences Inc falls 5.47 percent for July 26 - Equities.com
Equities News
over a week ago at marketingsentinel.com         
Kaleido Biosciences Inc. s -22.12 percent Loss This Week Just Tells Us Something New - Marketing Sen...
M
over a week ago at seekingalpha.com         
Seres Therapeutics extends losses as Goldman Sachs downgrades on trial setback - Seeking Alpha
seekingalpha News
over two weeks ago at www.equities.com         
Kaleido Biosciences Inc gains 5.97 percent for July 16 - Equities.com
Equities News
over three weeks ago at www.equities.com         
Kaleido Biosciences Inc gains 1.1390 percent for July 09 - Equities.com
Equities News
over a month ago at www.equities.com         
Kaleido Biosciences Inc gains 1.2800 percent for July 02 - Equities.com
Equities News
over a month ago at www.macroaxis.com         
Acquisition by Prener Anne of 15000 shares of Kaleido Biosciences subject to Rule 16b-3
Macroaxis News
over a month ago at finance.yahoo.com         
Is Kaleido BioSciences, Inc. A Good Stock To Buy - Yahoo Finance
Yahoo News
over a month ago at www.equities.com         
Kaleido Biosciences Inc gains 7.3870 percent for June 28 - Equities.com
Equities News
over a month ago at www.equities.com         
Kaleido Biosciences Inc rose 13.4480 percent for June 24 - Equities.com
Equities News
over a month ago at www.equities.com         
Kaleido Biosciences Inc gains 1.0400 percent for June 21 - Equities.com
Equities News
over a month ago at www.equities.com         
Kaleido Biosciences Inc gains 1.3330 percent for June 14 - Equities.com
Equities News
over a month ago at www.equities.com         
Kaleido Biosciences Inc falls -8.6600 percent for June 11 - Equities.com
Equities News
over a month ago at www.equities.com         
Kaleido Biosciences Inc gains 3.6470 percent for June 10 - Equities.com
Equities News
There is far too much social signal, news, headlines, and media speculation about Kaleido Biosciences that is available to investors today. That information is available publicly through Kaleido media outlets and privately through word of mouth or via Kaleido internal channels. However, regardless of the origin, that massive amount of Kaleido data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kaleido Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kaleido Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kaleido Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kaleido Biosciences alpha.

Kaleido Biosciences Performance against DOW

 Price Growth (%)  
      Timeline 
1
Kaleido Biosciences exotic insider transaction detected05/13/2021
2
Kaleido Biosciences Inc falls -1.6550 percent for June 09 - ...06/10/2021
3
Kaleido Biosciences Inc gains 1.3330 percent for June 14 - E...06/14/2021
4
Financial Statements06/17/2021
5
Kaleido Biosciences Inc gains 7.3870 percent for June 28 - E...06/28/2021
6
EPS Estimate06/30/2021
7
Acquisition by Prener Anne of 15000 shares of Kaleido Biosci...07/01/2021
8
Kaleido Biosciences Inc gains 1.2800 percent for July 02 - E...07/02/2021
9
Seres Therapeutics extends losses as Goldman Sachs downgrade...07/23/2021
10
Setback of Seress late-stage candidate challenges microbiome...07/30/2021
11
EPS Reported08/02/2021
Please see Kaleido Biosciences Hype Analysis, Kaleido Biosciences Correlation and Kaleido Biosciences Performance. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.